Treatment and secondary prophylaxis of VTE in the cancer patient: current status.
Lee
Agnes Y Y
AY
Hamilton Civic Hospitals Research Center, Hamilton, Canada. alee@mcmaster.ca
D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D006495:Heparin, Low-Molecular-Weight